Breaking Through: Renewing Attention to Cancer Pain

April 2010
Pain Community News;Spring2010, Vol. 10 Issue 2, p1
The article discusses the breakthrough cancer pains that affect the life of the person diagnosed with cancer. It mentions that this kind of cancer pain interferes the ability to manage other aspects of cancer treatment. According to Will Rowe, American Pain Foundation's chief executive officer, this pain leaves a lot of patients and their families fearful to the next laming episodes of cancer treatment because breakthrough cancer pains come out without warning.


Related Articles

  • Fast Facts on Breakthrough Cancer Pain.  // Pain Community News;Spring2010, Vol. 10 Issue 2, p6 

    The article presents questions and answers related to breakthrough cancer pain including the definition of breakthrough cancer pain, how many people are affected, and how to treat breakthrough cancer pain.

  • Blue Scorpion Venom Remedy for Cancer Pain. Klotter, Jule // Townsend Letter;Aug/Sep2013, Issue 361/362, p30 

    The article discusses the study "Cancer Pain Management With a Venom of Blue Scorpion Endemic in Cuba, Called Rhopalurus junceus Escozul," by L. DiLorenzo and colleagues, published in a 2012 issue of "Open Cancer Journal." It reports the ability of the drug Escozul to relieve pain of cancer...

  • Primary Care of the Patient with Cancer. Smith, George F.; Toonen, Timothy R. // American Family Physician;4/15/2007, Vol. 75 Issue 8, p1207 

    Care of patients with cancer can be enhanced by continued involvement of the primary care physician. The physician's role may include informing the patient of the diagnosis, helping with decisions about treatment, providing psychological support, treating intercurrent disease, continuing...

  • Les principaux syndromes douloureux liés au cancer. George, B.; Delfieu, D. // Oncologie;Oct2008, Vol. 10 Issue 10, p591 

    Pains associated with cancer are multiple, with various physiopathological origins and imply various aetiologies. Individual detection and understanding of each of these pains is fundamental since they necessitate treatments that may differ. Pain related to the tumour process and its...

  • The Malignant Psoas Syndrome Revisited: Case Report, Mechanisms, and Current Therapeutic Options. Stevens, Mark John; Atkinson, Charlotte; Broadbent, Andrew M. // Journal of Palliative Medicine;Feb2010, Vol. 13 Issue 2, p211 

    The malignant psoas syndrome (MPS) is a rare and challenging cancer pain state that is often refractory to rational polymodal analgesic therapy. We describe the first case of cervix cancer-related MPS due to extrinsic psoas muscle infiltration and review the therapeutic trajectory and outcome....

  • Management of cancer pain: ESMO Clinical Recommendations. Jost, L.; Roila, F. // Annals of Oncology;May2009 Supplement 4, Vol. 20, piv170 

    The article presents clinical recommendations for the management of cancer pain from the European Society for Medical Oncology (ESMO). The incidence of pain is based on the fact that over 80 percent of cancer patients with advanced metastatic disease suffer pain due to direct tumor infiltration....

  • Assessment and treatment of breakthrough cancer pain: from theory to clinical practice. Vellucci, Renato; Mediati, Rocco Domenico; Gasperoni, Silvia; Mammucari, Massimo; Marinangeli, Franco; Romualdi, Patrizia // Journal of Pain Research;Sep2017, Vol. 10, p2147 

    Breakthrough cancer pain (BTcP) is a common condition in oncological patients. However, its management is still suboptimal. Improved knowledge of BTcP and its management in clinical practice may have immediate importance for all physicians involved in the supportive care of cancer patients. This...

  • ADOLESCENT BARRIERS TO PAIN MANAGEMENT. Ameringer, Suzanne; Ward, Sandra; Serlin, Ronald; Hughes, Susan // Oncology Nursing Forum;Jan2007, Vol. 34 Issue 1, p211 

    Patient-related barriers to pain management are one of the determinants of poor pain management in adults but these barriers have rarely been examined in adolescents. Barriers interfere with critical coping efforts such as reporting pain and using medications. Evidence suggests that adolescents...

  • Diamyd Medical's Phase II study in cancer pain fully recruited.  // Biomedical Market Newsletter;5/25/2012, Vol. 21, p1 

    The article presents information on the Diamyd Medical AB which has recruited the last patient for the treatment of cancer pain with the drug candidate NP2 Enkephalin. It informs that this clinical trial is the first placebo-controlled clinical trial of a drug candidate. As per Peter Zerhouni,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics